Please try another search
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Rahul Jayant Nachane | 60 | 1993 | CEO, MD, Chief Ethics Counsellor & Executive Director |
Rajesh Narayan Lawande | 48 | 2005 | Whole Time Director & CFO |
Ajita Rahul Nachane | 55 | 2014 | Non Executive Woman Director |
Jayaram Sitaram | 59 | 2015 | Independent Non-Executive Director |
Dhananjay Mungale | - | 2024 | Independent Director |
Sarala Menon | - | 2021 | Non-Executive Independent Woman Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review